Literature DB >> 1825776

NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells.

J C Richardson1, R K Akkina.   

Abstract

Purified viral preparations of influenza A virus were examined for the presence of NS2 protein hitherto considered as a viral nonstructural protein that is present only in infected cells. Analysis of purified virus by radioimmunoprecipitation with monospecific antisera to NS2 revealed its presence in the virus particle suggesting that it is a viral structural protein. NS2 protein was also shown to be phosphorylated in infected cells in this study. This brings the number of influenza virus phosphoproteins to three which include NP, NS1, and NS2. These observations raise important questions about the role of NS2 in the replication of influenza virus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825776     DOI: 10.1007/bf01319232

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  17 in total

1.  Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription.

Authors:  R A Lamb; P W Choppin
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

2.  Segment 8 of the influenza virus genome is unique in coding for two polypeptides.

Authors:  R A Lamb; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

Review 3.  Transcription and replication of rhabdoviruses.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1987-03

4.  Expression of defective-interfering influenza virus-specific transcripts and polypeptides in infected cells.

Authors:  R K Akkina; T M Chambers; D P Nayak
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

5.  Isolation and properties of a temperature-sensitive mutant (ts 412) of an influenza A virus recombinant with a ts lesion in the gene coding for the nonstructural protein.

Authors:  I Koennecke; C B Boschek; C Scholtissek
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

6.  Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus.

Authors:  R A Lamb; C J Lai
Journal:  Cell       Date:  1980-09       Impact factor: 41.582

7.  Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses.

Authors:  G L Smith; J Z Levin; P Palese; B Moss
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

8.  Influenza virus-specific RNA and protein syntheses in cells infected with temperature-sensitive mutants defective in the genome segment encoding nonstructural proteins.

Authors:  A J Wolstenholme; T Barrett; S T Nichol; B W Mahy
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

9.  Relationship between the messenger RNAs transcribed from two overlapping genes of influenza virus.

Authors:  S C Inglis; M J Gething; C M Brown
Journal:  Nucleic Acids Res       Date:  1980-08-25       Impact factor: 16.971

10.  Intracellular localization of the viral polymerase proteins in cells infected with influenza virus and cells expressing PB1 protein from cloned cDNA.

Authors:  R K Akkina; T M Chambers; D R Londo; D P Nayak
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

View more
  36 in total

1.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion.

Authors:  Nicole L La Gruta; William T Rothwell; Tania Cukalac; Natasha G Swan; Sophie A Valkenburg; Katherine Kedzierska; Paul G Thomas; Peter C Doherty; Stephen J Turner
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

2.  Genetic analysis of the nonstructural (NS) genes of H9N2 chicken influenza viruses isolated in China during 1998-2002.

Authors:  Shuai Wang; Wei-Min Shi; Aaron Mweene; Hui-Ling Wei; Gui-Rong Bai; Jin-Hua Liu
Journal:  Virus Genes       Date:  2005-12       Impact factor: 2.332

3.  Structure-based design of NS2 mutants for attenuated influenza A virus vaccines.

Authors:  Hatice Akarsu; Kiyoko Iwatsuki-Horimoto; Takeshi Noda; Eiryo Kawakami; Hiroaki Katsura; Florence Baudin; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  Virus Res       Date:  2010-10-21       Impact factor: 3.303

4.  Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus.

Authors:  G Whittaker; I Kemler; A Helenius
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

5.  The N-terminal half of the influenza virus NS1 protein is sufficient for nuclear retention of mRNA and enhancement of viral mRNA translation.

Authors:  R M Marión; T Aragón; A Beloso; A Nieto; J Ortín
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

6.  Receptor tyrosine kinase inhibitors block multiple steps of influenza a virus replication.

Authors:  Naveen Kumar; Yuhong Liang; Tristram G Parslow; Yuying Liang
Journal:  J Virol       Date:  2011-01-05       Impact factor: 5.103

7.  Hijacking of host calreticulin is required for the white spot syndrome virus replication cycle.

Authors:  Apiruck Watthanasurorot; Enen Guo; Sirinit Tharntada; Chu-Fang Lo; Kenneth Söderhäll; Irene Söderhäll
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

8.  Tyrosine 132 phosphorylation of influenza A virus M1 protein is crucial for virus replication by controlling the nuclear import of M1.

Authors:  Shanshan Wang; Zhendong Zhao; Yuhai Bi; Lei Sun; Xiaoling Liu; Wenjun Liu
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

9.  Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.

Authors:  E Hatada; S Saito; R Fukuda
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Serum- and glucocorticoid-regulated kinase 1 is required for nuclear export of the ribonucleoprotein of influenza A virus.

Authors:  Judith G Alamares-Sapuay; Luis Martinez-Gil; Silke Stertz; Matthew S Miller; Megan L Shaw; Peter Palese
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.